Clinical Trials · NCT00044707
Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 24
- Start date
- Aug 2002
- Locations
- 1 site, United States
- Primary endpoint
- To determine the effect of pramlintide on the PK of an oral medication